Skip to main content
KZIA logo

Kazia Therapeutics Limited

KZIANASDAQHealthcareBiotechnology

$7.87Today:- (-)1Y +19.73%

As of Oct 26, 2026 close

Market cap
$24.56M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$4.86$17.40
Volume (live)
-
Avg. volume (3M)
262.99K

Kazia Therapeutics (KZIA) Cash Flow Statement

In fiscal 2025 (fiscal year ended Jun 30, 2025), Kazia Therapeutics used AUD 13.28M of cash in operating activities. Free cash flow was −AUD 13.28M.

Kazia Therapeutics Cash Flow Statement Analysis

Values in millions AUD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Kazia Therapeutics Limited (KZIA) - Annual data in millions AUD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period endingJun 2025Jun 2024Jun 2023Jun 2022Jun 2021Jun 2020Jun 2019Jun 2018Jun 2017
Operating Activities
Net Income-20.70-26.78-20.47-25.01-8.42-12.47-10.27-6.04-10.67
Depreciation & Amortization0.931.871.871.871.271.081.081.551.41
Deferred Income Tax0.000.000.000.000.000.171.813.973.51
Stock Based Compensation0.650.531.161.680.640.260.250.170.52
Change in Working Capital-3.0110.004.330.86-5.591.670.351.54-4.02
Change in Accounts Receivable3.800.013.45-0.01-5.030.360.831.72-4.02
Change in Accounts Payable-4.9510.740.57-0.531.010.000.000.000.00
Change in Other Working Capital-13.39-0.470.580.15-1.091.31-0.47-0.19-0.23
Other Operating Activities7.104.52-2.320.152.510.470.06-9.841.33
Net Cash from Operating Activities-13.28-9.58-15.16-22.76-9.11-8.81-6.71-8.66-11.43
Investing Activities
Capital Expenditures0.000.000.000.000.000.000.000.00-0.01
Acquisitions0.000.000.00-2.370.000.000.000.00-7.10
Sales/Maturities of Investments0.000.000.000.000.000.002.360.000.00
Other Investing Activities0.000.000.00-2.370.000.002.360.15-0.01
Net Cash from Investing Activities0.000.000.00-2.370.000.002.360.15-7.12
Financing Activities
Debt Repayment0.00-0.370.000.000.000.000.000.000.00
Common Stock Issued15.985.5812.973.7328.1112.143.820.000.00
Other Financing Activities2.32-0.38-0.40-0.49-1.670.000.000.00-0.02
Net Cash from Financing Activities15.985.9912.973.7328.1112.143.820.00-0.02
Summary
Effect of Forex Changes on Cash-0.020.010.061.18-0.180.000.020.01-0.43
Net Change in Cash2.69-3.58-2.12-21.4018.823.33-0.52-8.50-19.00
Cash at Beginning of Period1.665.247.3627.598.765.435.9614.4633.45
Cash at End of Period4.351.665.247.3627.598.765.435.9614.45
Free Cash Flow-13.28-9.58-15.16-22.76-9.11-8.81-6.71-8.66-11.45

Source: Company financial statements from annual and quarterly filings. Data as of Dec 31, 2025. Data sources and methodology

Frequently Asked Questions About Kazia Therapeutics Cash Flow

What is Kazia Therapeutics's free cash flow?

Kazia Therapeutics had negative free cash flow of AUD 13.28M in fiscal 2025 (fiscal year ended Jun 30, 2025).

Does Kazia Therapeutics pay dividends or buy back shares?

Kazia Therapeutics's cash flow statement for fiscal 2025 shows no dividend payments or share repurchases.

What is free cash flow?

Free cash flow is operating cash flow minus capital expenditures. It is the cash a company has left for dividends, buybacks, debt repayment or acquisitions after funding its operations and investment. Full definition